Paratus Sciences
PrivateLast Round
Series A
Feb 27, 2023
Total Funding Raised
$100M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Paratus Sciences operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Series A round in February 2023.
Paratus Sciences is a biotechnology company that develops novel therapeutics by leveraging evolutionary insights from bat biology to address serious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Paratus Sciences Comparables
Compare Paratus Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Fauna Bio | 84% | |
| Valo Health | 81% | |
| Odyssey | 79% |
For institutional investors. Book with your work email.
Paratus Sciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Paratus Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EcoR1 Capital | Series A |
| ClavystBio | Series A |
| ARCH Venture Partners | Series A |
| Alexandria Venture Investments | Series A |
| Polaris Partners | Series A |
| Leaps by Bayer | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 36% MoM.
- Jul 1, 2026
Grew 18% QoQ from 17 to 20 employees.
For institutional investors. Book with your work email.
Paratus Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Paratus Sciences's valuation, stock price, and market status.
Is Paratus Sciences a public or private company?
Paratus Sciences is a private company.
What is the current stock price of Paratus Sciences?
Paratus Sciences is a private company, so its shares have no public market price. Caplight tracks Paratus Sciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Paratus Sciences worth (valuation)?
Valuation information for Paratus Sciences is not publicly available.
Can I buy Paratus Sciences stock?
Paratus Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Paratus Sciences's last funding round?
Paratus Sciences's most recent funding round was Series A on February 27, 2023.
Who are the main investors in Paratus Sciences?
Key investors in Paratus Sciences include EcoR1 Capital, ClavystBio, ARCH Venture Partners, Polaris Partners, Leaps by Bayer.
Will Paratus Sciences IPO soon?
No public IPO plans have been announced for Paratus Sciences.
How can I track Paratus Sciences secondary market activity?
Caplight tracks bids, offers, and trades in Paratus Sciences's shares on secondary markets.